CareDx Brings Personalized Care to Transplant with the Launch of KIRA Immuno-optimization Study at CEOT
“The KIRA study is a major leap forward in AlloSure utility. I am glad
“Immuno-optimization is near to my heart, and this has always been our goal to bring personalized care to transplantation. We are glad to partner with the transplant community as we launch the KIRA study at CEOT,” said
Chief Marketing Officer
Source: CareDx, Inc.